Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T02:28:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-27T02:35:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T05:17:24.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T07:50:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    An error page (403 Forbidden) is now shown instead of the study record content. This indicates an access restriction rather than an update to the study details.
    Difference
    20%
    Check dated 2026-09-22T02:27:55.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the study page, indicating a minor backend/template update. No study data or displayed information appears to be affected.
    Difference
    0.1%
    Check dated 2026-08-31T23:28:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.